Tofacitinib for the treatment of severe rare skin diseases: a narrative review.
Purpose: Autoimmune bullous diseases, connective tissue diseases, and vasculitis represent a group of severe rare skin diseases. While glucocorticoids and immunosuppressive agents serve as standard treatments for these diseases, their efficacy is limited due to adverse side effects, indicating the n...
| Publicado en: | European Journal of Clinical Pharmacology Vol. 80; no. 4; pp. 481 - 493 |
|---|---|
| Autores principales: | , , |
| Formato: | review tables/charts Journal Article |
| Publicado: |
Springer Nature
Apr2024
|
| Acceso en línea: | Ver este registro en EBSCOhost |